Document Type : Review Article

Authors

1 Multiple Sclerosis Research Center, Neuroscience institute, Tehran University of Medical Sciences, Tehran, Iran

2 Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

3 School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

4 Universal Council of Epidemiology, Universal Scientific Education and Research Network, Tehran University of Medical Sciences, Tehran, Iran

5 Multiple Sclerosis Research Center, Neuroscience institute, Tehran University of Medical Sciences, Tehran, Iran Universal Council of Epidemiology, Universal Scientific Education and Research Network, Tehran University of Medical Sciences, Tehran, Iran

Abstract

Background: This study was conducted to evaluate the relationship between retinal layer thickness (RLT) and cognition in patients with multiple sclerosis (MS).
Methods: We searched PubMed, Scopus, Embase, Web of Science, and Google Scholar. The search strategy included the MeSH and text words as [“ora serrata” OR “retina” OR (“coherence tomography” AND “optical”) OR “OCT tomography” OR (tomography AND OCT) OR “optical coherence tomography” OR “OCT” OR “retinal thickness” OR “inner plexiform layer” OR “nerve fiber layer” OR “ganglion cell layer” OR “inner nuclear layer” OR “outer plexiform layer” OR “outer nuclear layer” OR “external limiting membrane” OR “inner segment layer” OR “outer segment layer” OR “retinal pigment epithelium”] AND [“cognition”*  OR “cognitive function”* OR (function* AND cognitive)] AND [(sclerosis AND multiple) OR (sclerosis AND disseminated) OR "disseminated sclerosis" OR "multiple sclerosis" OR "acute fulminating"].
Results: The literature search revealed 1090 articles; after deleting duplicates, 980 remained. Finally, 14 studies were included. Totally, 1081 patients were evaluated. Mean age ranged from 31 to 55 years. In some studies, there was a correlation between cognition and retinal thickness, while others did not confirm this finding. Some authors found cognitive impairment (CI) in patients with MS with RLT.
Conclusion: The results of this systematic review show that there are discrepancies between the results of studies regarding the relationship between RLT and cognition status in patients with MS. Further studies with more included original studies and meta-analysis are recommended.

Keywords

  1. Azimi A, Hanaei S, Sahraian MA, Mohammadifar M, Ramagopalan SV, Ghajarzadeh M. Prevalence of sexual dysfunction in women with multiple sclerosis: A systematic review and meta-analysis. Maedica (Bucur) 2019; 14(4): 408-12.
  2. Rocca MA, Amato MP, De Stefano N, Enzinger C, Geurts JJ, Penner IK, et al. Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis. Lancet Neurol 2015; 14(3): 302-17.
  3. Esmael A, Elsherif M, Abdelsalam M, Sabry D, Mamdouh M, Belal T. Retinal thickness as a potential biomarker of neurodegeneration and a predictor of early cognitive impairment in patients with multiple sclerosis. Neurol Res 2020; 42(7): 564-74.
  4. Cortese R, Collorone S, Ciccarelli O, Toosy AT. Advances in brain imaging in multiple sclerosis. Ther Adv Neurol Disord 2019; 12: 1756286419859722.
  5. Baetge SJ, Dietrich M, Filser M, Renner A, Stute N, Gasis M, et al. Association of retinal layer thickness with cognition in patients with multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 2021; 8(4): e1018.
  6. Balk LJ, Cruz-Herranz A, Albrecht P, Arnow S, Gelfand JM, Tewarie P, et al. Timing of retinal neuronal and axonal loss in MS: A longitudinal OCT study. J Neurol 2016; 263(7): 1323-31.
  7. Birkeldh U, Manouchehrinia A, Hietala MA, Hillert J, Olsson T, Piehl F, et al. Retinal nerve fiber layer thickness associates with cognitive impairment and physical disability in multiple sclerosis. Mult Scler Relat Disord 2019; 36: 101414.
  8. Britze J, Frederiksen JL. Optical coherence tomography in multiple sclerosis. Eye (Lond) 2018; 32(5): 884-8.
  9. Dorr J, Wernecke KD, Bock M, Gaede G, Wuerfel JT, Pfueller CF, et al. Association of retinal and macular damage with brain atrophy in multiple sclerosis. PLoS One 2011; 6(4): e18132.
  10. Saidha S, Al-Louzi O, Ratchford JN, Bhargava P, Oh J, Newsome SD, et al. Optical coherence tomography reflects brain atrophy in multiple sclerosis: A four-year study. Ann Neurol 2015; 78(5): 801-13.
  11. Gandhi S, Hagemeier J, Chandra A, Sanai SA, Jakimovski D, Ahmed R, et al. Optical coherence tomography is associated with development of brain atrophy in relapsing-remitting multiple sclerosis: a longitudinal 5-year follow-up study (P4.142). Neurology 2016; 86(16 Suppl): 4.
  12. Modesti PA, Reboldi G, Cappuccio FP, Agyemang C, Remuzzi G, Rapi S, et al. Panethnic differences in blood pressure in europe: a systematic review and meta-analysis. PLoS One 2016; 11(1): e0147601.
  13. Dajani DR, Uddin LQ. Demystifying cognitive flexibility: Implications for clinical and developmental neuroscience. Trends Neurosci 2015; 38(9): 571-8.
  14. Frau J, Fenu G, Signori A, Coghe G, Lorefice L, Barracciu MA, et al. A cross-sectional and longitudinal study evaluating brain volumes, RNFL, and cognitive functions in MS patients and healthy controls. BMC Neurol 2018; 18(1): 67.
  15. Naseer MA, Fathi S, Labib DM, Khalil DH, Aboulfotooh AM, Magdy R. Early detection of cognitive dysfunction in patients with multiple sclerosis: Implications on outcome. Brain Impairment 2020; 21(2): 208-16.
  16. Lima C, Varela R, d'Almeida OC, Alves C, Bernardes R, Santana I, et al. The role of optical coherence tomography as a predictor of cognitive impairment in multiple sclerosis. Multiple Sclerosis Journal 2018; 24: 865-6.
  17. Gilroy M, Lichtman-Mikol S, Razmjou S, Santiago-Martinez C, Bernitsas E, Seraji-Bozorgzad N. Retinal structure reflects clinical disease severity in relapsing remitting multiple sclerosis patients (P1.410). Neurology 2018; 90(15 Suppl): P1.410.
  18. Coric D, Balk LJ, Verrijp M, Eijlers A, Schoonheim MM, Killestein J, et al. Cognitive impairment in patients with multiple sclerosis is associated with atrophy of the inner retinal layers. Mult Scler 2018; 24(2): 158-66.
  19. May FJ, Cohen JA, Bermel R, Fox RJ, Ontaneda DD. Optical coherence tomography measures correlate with cognitive function in progressive multiple sclerosis. Proceedings of the 3rd sAnnual Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2018; 2018 Feb 1-3; San Diego, CA, USA.
  20. Sedighi B, Shafa MA, Abna Z, Ghaseminejad AK, Farahat R, Nakhaee N, et al. Association of cognitive deficits with optical coherence tomography changes in multiple sclerosis patients. J Mult Scler 2014; 1(2): 117.
  21. Albrecht P, Ringelstein M, Muller AK, Keser N, Dietlein T, Lappas A, et al. Degeneration of retinal layers in multiple sclerosis subtypes quantified by optical coherence tomography. Mult Scler 2012; 18(10): 1422-9.
  22. Petzold A, Balcer LJ, Calabresi PA, Costello F, Frohman TC, Frohman EM, et al. Retinal layer segmentation in multiple sclerosis: A systematic review and meta-analysis. Lancet Neurol 2017; 16(10): 797-812.
  23. Petracca M, Sumowski J, Fabian M, Miller A, Lublin F, Inglese M. Looking into cognitive impairment in primary-progressive multiple sclerosis. Eur J Neurol 2018; 25(1): 192-5.
  24. Pietroboni AM, Dell'Arti L, Caprioli M, Scarioni M, Carandini T, Arighi A, et al. The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients. Mult Scler 2019; 25(1): 31-8.
  25. Graham EC, You Y, Yiannikas C, Garrick R, Parratt J, Barnett MH, et al. Progressive loss of retinal ganglion cells and axons in nonoptic neuritis eyes in multiple sclerosis: A longitudinal optical coherence tomography study. Invest Ophthalmol Vis Sci 2016; 57(4): 2311-7.
  26. Filippi M, Rocca MA, Benedict RH, DeLuca J, Geurts JJ, Rombouts SA, et al. The contribution of MRI in assessing cognitive impairment in multiple sclerosis. Neurology 2010; 75(23): 2121-8.
  27. Fisher E, Rudick RA, Simon JH, Cutter G, Baier M, Lee JC, et al. Eight-year follow-up study of brain atrophy in patients with MS. Neurology 2002; 59(9): 1412-20.
  28. Frohman EM, Dwyer MG, Frohman T, Cox JL, Salter A, Greenberg BM, et al. Relationship of optic nerve and brain conventional and non-conventional MRI measures and retinal nerve fiber layer thickness, as assessed by OCT and GDx: A pilot study. J Neurol Sci 2009; 282(1-2): 96-105.
  29. Abdel NM, Fathi S, Roshdy NK, Labib DM, Khalil DH, Ibrahim W, et al. Cognitive and physical disability in Egyptian patients with multiple sclerosis: Genetic and optical coherence tomography study. Neurol Res 2019; 41(7): 644-51.
  30. Nguyen J, Rothman A, Fitzgerald K, Whetstone A, Syc-Mazurek S, Aquino J, et al. Visual pathway measures are associated with neuropsychological function in multiple sclerosis. Curr Eye Res 2018; 43(7): 941-8.
  31. El Ayoubi NK, Ghassan S, Said M, Allam J, Darwish H, Khoury SJ. Retinal measures correlate with cognitive and physical disability in early multiple sclerosis. J Neurol 2016; 263(11): 2287-95.
  32. Giedraitiene N, Kizlaitiene R, Kaubrys G, Mockeviciute E, Noreikyte M, Strupaite R, et al. Association of cognitive impairment with optical coherence tomography and magnetic resonance imaging changes in multiple sclerosis patients. Multiple Sclerosis Journal 2015; 21: 362.
  33. Gencer M, Delipoyraz I, Buttanri B, Turkoglu R, Cetinkaya Y, Tireli H. Association of retinal nerve fiber layer thickness with disease disability, disease duration, SF-36, and PASAT scores in multiple sclerosis. J Neurol Sci 2013; 30(4): 702-10.